The Biden Cancer Initiative’s Oncology Clinical Trial Information Commons (OCTIC), a shared platform where all information about clinical trials can be stored and accessed for patient matching and other data mining, found an engaged partner with Massive Bio.  TrialSite News profiled Massive Bio and its founder Dr. Selin Kurnaz back in January 2019. It appears Dr. Kurnaz is executing on a very interesting collaborative with big potential for oncology research matching of trials to patients.

What is the Clinical Trial Information Commons

The Argus Press reports that the CTIC is a shared platform where all information about clinical trials can be stored and accessed for patient mapping. CTIC includes the following founding organizations:

  • Biden Cancer Initiative
  • Massive Bio
  • BreastCancerTrials.org
  • Cancer Commons
  • Citizen
  • EmergingMed
  • GenomOncology
  • Sarah Cannon Research Institute
  • IBM Watson Health
  • Synapse

The collective announced the news at the ASCO sessions in Chicago on June 1, 2019.  This system will employ a single set of terms and rules, including a user-friendly interface for biopharma sponsors to readily enter and update their trials.

Massive Bio is an active player in the formation of the group. It connects patients and their treating oncologists to the best available treatment options. See TrialSite News profile of Massive Bio. 

Source: Argus-press

Pin It on Pinterest